Procedure Type
Non SurgicalProcedure Duration
1 - 3 HoursHospital Stay (Days)
5-6 daysInduction therapy in India offers international patients access to specialized hematology care, advanced cancer treatment facilities, and personalized treatment programs at competitive costs. As the initial phase of treatment for certain blood cancers, induction therapy aims to reduce cancer cells and achieve remission.
India has become a trusted destination for international healthcare, offering experienced hematologists, modern diagnostic laboratories, and comprehensive supportive care.
For patients from the Middle East, Africa, and CIS countries, MedTripz simplifies treatment arrangements through specialist consultations, hospital selection, cost estimates, medical travel assistance, and follow-up coordination.
Induction therapy is the first major phase of treatment designed to bring a disease under control.
In hematology, induction chemotherapy is commonly used for certain acute blood cancers. Its primary objective is to destroy as many abnormal cells as possible and achieve remission.
Remission means that the disease has responded to treatment according to established medical criteria. It does not necessarily mean that every cancer cell has disappeared or that further treatment is unnecessary.
Induction therapy may involve chemotherapy, targeted medicines, steroids, or other medications depending on the diagnosis.
Induction therapy is commonly recommended for patients requiring prompt treatment of aggressive blood cancers.
Induction treatment aims to reduce abnormal leukemia cells and restore healthy blood cell production.
Treatment intensity depends on age, genetic findings, overall health, and medical fitness.
Induction therapy is an important initial treatment phase for ALL.
Doctors select medication combinations according to the patient's age, leukemia subtype, and individual risk factors.
Certain other blood cancers may require an initial intensive treatment phase.
The treatment approach depends on the specific diagnosis and specialist recommendations.
Induction therapy should not be confused with stem cell transplantation or subsequent consolidation treatment.
The Induction Therapy Cost in India depends on the treatment protocol, medications, hospitalization, investigations, and supportive care requirements.
These indicative prices are published by MedTripz. Final costs depend on the prescribed treatment protocol, hospital quotation, and complications.
Disease Characteristics: The diagnosis and biological features influence medication selection.
Treatment Protocol: Intensive and lower-intensity regimens involve different expenses.
Medication Requirements: Chemotherapy, targeted medicines, and supportive drugs affect costs.
Hospitalization: Extended inpatient monitoring increases accommodation and nursing expenses.
Blood Transfusions: Some patients require repeated red blood cell or platelet transfusions.
Infection Management: Antibiotics, antifungal medicines, and additional investigations may increase expenses.
Response Assessment: Repeat laboratory tests and bone marrow examinations contribute to overall costs.
A hospital quotation may include:
Initial hematology consultation
Routine diagnostic investigations
Prescribed chemotherapy administration
Standard inpatient accommodation
Nursing supervision
Routine blood monitoring
Supportive medications
Treatment response assessment
Patients should confirm whether blood products, intensive care, advanced medications, infection treatment, and extended hospitalization are included.
MedTripz assists international patients in reviewing these details before treatment.
Induction chemotherapy in India follows an individualized treatment plan developed by the hematology team.
Specialists review the diagnosis, previous investigations, medical history, and current health.
Doctors select an appropriate medication combination and schedule.
The treatment plan considers disease characteristics, organ function, and possible complications.
Chemotherapy may be delivered intravenously or through other prescribed routes.
Some patients require a central venous catheter for repeated medication administration and blood testing.
Medical teams monitor blood counts, manage side effects, and provide transfusions or infection treatment when necessary.
Blood tests and bone marrow examinations help determine whether the treatment has achieved its intended response.
Additional treatment may be recommended depending on the results.
Pre-treatment investigations help doctors assess treatment suitability and identify potential risks.
A complete blood count measures red blood cells, white blood cells, and platelets.
Bone marrow testing helps establish the diagnosis and assess abnormal cell populations.
Specialized investigations identify disease characteristics that may influence treatment selection.
These tests help determine whether the body can tolerate prescribed medications.
Selected chemotherapy medicines may affect heart function, making cardiac evaluation necessary.
Screening helps identify infections that may require treatment or additional precautions.
The duration varies according to the diagnosis, treatment protocol, and patient's response.
Medication administration may occur over several days, but the complete induction phase can extend over several weeks.
Patients receiving intensive chemotherapy may require prolonged hospitalization while their blood counts recover.
Although the MedTripz treatment listing indicates a five-to-six-day hospital stay, this should not be considered the standard duration for intensive leukemia induction.
Some patients require several weeks of inpatient monitoring.
The treating hematologist should provide an individualized timeline before treatment begins.
After induction, specialists evaluate whether remission has been achieved.
The assessment may include blood counts, bone marrow testing, and measurable residual disease testing when appropriate.
Patients who achieve remission may require further treatment to reduce the risk of recurrence.
Those who do not achieve the expected response may need a revised treatment plan.
Induction therapy is generally the beginning of a broader treatment pathway, not a complete treatment program by itself.
Appropriately selected induction treatment may provide several important benefits.
Disease Control: Treatment aims to reduce abnormal cancer cells.
Remission Induction: Some patients achieve remission after the initial treatment phase.
Improved Blood Cell Production: Successful treatment may allow normal blood formation to recover.
Further Treatment Planning: Response assessments help specialists determine subsequent care.
Individualized Treatment: Medication combinations can be selected according to clinical and biological findings.
Outcomes vary, and remission cannot be guaranteed.
Induction chemotherapy may cause significant side effects because it can affect healthy cells alongside cancer cells.
Potential complications include:
Nausea and vomiting
Fatigue and weakness
Hair loss
Mouth sores
Reduced appetite
Low blood cell counts
Increased infection risk
Bleeding or bruising
Organ-related complications
Fertility problems
Some complications require urgent hospitalization.
Patients should immediately inform their medical team about fever, unusual bleeding, breathing difficulties, or severe weakness.
Supportive care is essential because treatment may temporarily suppress healthy blood cell production.
Healthcare teams monitor patients for infections and prescribe preventive or therapeutic medicines when indicated.
Red blood cell and platelet transfusions may be necessary during periods of low blood counts.
Dietary guidance helps patients maintain adequate nutrition during treatment.
Medicines may be prescribed to manage nausea, pain, mouth sores, and other treatment-related symptoms.
India offers international patients access to specialized hematology services supported by established healthcare infrastructure.
Selected hospitals provide multidisciplinary care involving hematologists, oncology nurses, laboratory specialists, and supportive care professionals.
Modern laboratories support blood testing, bone marrow evaluation, and specialized disease assessments.
International patients can compare treatment quotations while considering clinical expertise and available facilities.
Specialized inpatient services help manage complications associated with intensive treatment.
Hospital selection should prioritize infection-control practices, emergency support, and hematology expertise.
Patients from the Middle East, Africa, and CIS countries often need assistance organizing treatment abroad.
MedTripz supports international patients with:
Medical report review coordination
Hematology specialist consultations
Hospital selection assistance
Preliminary treatment quotations
Medical visa guidance
Accommodation arrangements
Interpreter coordination
Follow-up planning
Patients should share their diagnosis, bone marrow reports, blood test results, previous medications, and relevant medical history.
Because induction therapy may require prolonged hospitalization, patients should prepare for possible changes in their travel schedule.
International travel depends on blood count recovery, infection risk, clinical stability, and specialist approval.
Patients should arrange continued hematology care before returning home.
PRINCIPAL DIRECTOR & CHIEF HEMATOLOGY
PRINCIPAL DIRECTOR & PAEDIATRIC HEMATOLOGY
Director, Department of Hemato-Oncology & Bone Marrow Transplant
MedTripz acts as a medical tourism facilitator, helping international patients coordinate their healthcare journey.
Specialist Coordination: Assistance connecting with suitable hematology professionals.
Hospital Selection: Support identifying facilities appropriate for individual treatment needs.
Cost Transparency: Help reviewing quotations and possible additional expenses.
Medical Travel Support: Coordination of relevant travel and accommodation arrangements.
Follow-Up Assistance: Support communicating with treatment teams after discharge.
Clinical decisions remain the responsibility of qualified healthcare professionals.
MedTripz lists indicative costs between USD 15,000 and USD 20,000, with an average of USD 18,000.
Induction therapy describes a treatment phase. Chemotherapy is commonly used during this phase, sometimes alongside other medicines.
Intensive induction chemotherapy often requires hospitalization, although requirements vary by treatment protocol.
The treatment phase may last several weeks, depending on the diagnosis, medication schedule, and recovery.
No. Treatment response depends on disease characteristics, patient health, and other medical factors.
Yes. MedTripz can coordinate preliminary estimates after reviewing relevant medical records.
If you or a family member requires induction treatment, specialist evaluation can help determine an appropriate care plan.
MedTripz assists international patients with hematology consultations, hospital coordination, treatment quotations, and medical travel arrangements.
Contact MedTripz today to explore induction therapy options in India and receive personalized cost guidance.
Gurugram, India
Gurugram, India
Gurugram, India
Honest Guidance, Reliable Support, Seamless Journeys.
Provide Us
Reports
Get Medical
Opinions
Pre-Arrival
Arrangements
Visa
Support
Assistance in
Treatments
Fly back and
Follow Up